Physician profile
Nancy Kwon
NPI 1629004577
$351.97
in general payments reported to CMS, 2019-2025
9 companies · $68.07 in 2025
The $68.07 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $90.95 · 2023: $25.23 · 2025: $68.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.98 | 2019 | |
| Maculogix, INC. | $68.20 | 2019 | |
| Visioneering Technologies, INC. | $50.13 | 2020 | |
| Optos, INC. | $40.82 | 2020 | |
| Biotissue Holdings INC. | $25.23 | 2023 | |
| Abbvie INC. | $23.96 | 2025 | |
| Apellis Pharmaceuticals, INC. | $22.33 | 2025 | Syfovre |
| Harrow Eye, LLC | $21.78 | 2025 | Vevye |
| Alcon Vision LLC | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.